Accelerate Diagnostics Inc reports results for the quarter ended in September 30 - Earnings Summary

Accelerate Diagnostics

08/11/2024 05:12

* Accelerate Diagnostics Inc  AXDX.OQ  reported a quarterly
adjusted loss of 59 cents​​ per share for the quarter ended
September 30, lower than the same quarter last year, when the
company reported EPS of 14 cents.  The lone analyst forecast for
the quarter was for a loss of 47 cents per share. 
    * Revenue fell 9.8% to $2.98 million from a year ago;
analysts
expected $3.02 million. 
    * Accelerate Diagnostics Inc's reported EPS for the quarter
was a
loss of 59 cents​.
    * Accelerate Diagnostics Inc shares had risen by 15.2% this
quarter and lost 49.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "strong buy"

This summary was machine generated from LSEG data November 8 at
05:12 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.47          -0.59          Missed
 Jun. 30 2024      -0.55          -0.53          Beat
 Mar. 31 2024      -0.72          -0.88          Missed
 Dec. 31 2023      -0.62          -0.81          Missed